ClinConnect ClinConnect Logo
Search / Trial NCT02614911

Characterization of Phenotype and Genotype of Early Onset Enteropathies

Launched by IMAGINE INSTITUTE · Nov 24, 2015

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Early Onset Entheropathy

ClinConnect Summary

This clinical trial is focused on understanding early onset enteropathies, which are conditions that cause severe intestinal problems in young children, particularly those who show symptoms within the first six years of life. The researchers want to learn more about the genetic and physical characteristics of these patients by collecting blood samples from them and their healthy family members. This information could help identify the causes of these conditions and improve future treatments.

To participate in this study, patients must have severe chronic intestinal issues that started at a young age, or they need to be a family member of someone affected, even if their symptoms appeared later. The study is currently recruiting participants of all ages and genders. If you decide to join, you can expect to provide a blood sample, and your involvement will contribute to important research that could benefit others facing similar health challenges in the future. It's important to note that individuals who have recently participated in other clinical trials are not eligible for this study.

Gender

ALL

Eligibility criteria

  • Main Inclusion Criteria:
  • Severe chronic enteropathy
  • Patients developing their first symptoms within the first 6 years of life and, in priority within the first two years of life, or patients with a disease of later onset, in case of a familial history suggestive of inherited mutations notably in families comprising several affected members
  • OR : Be a patient's relative, even if presenting with enteropathy of later onset.
  • Main Exclusion Criteria:
  • Subject having participated to any therapeutical clinical study in the 30 days preceding the inclusion in this study,

About Imagine Institute

The Imagine Institute is a leading research organization dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. Committed to fostering collaboration among scientists, clinicians, and industry partners, the Institute focuses on pioneering research in genetic and rare diseases. With a state-of-the-art facility and a multidisciplinary team of experts, the Imagine Institute aims to translate groundbreaking discoveries into effective therapies, ensuring that cutting-edge treatments are accessible to those in need. Its commitment to excellence and patient-centric approach positions the Imagine Institute as a key player in the landscape of clinical research and healthcare innovation.

Locations

Paris, , France

Paris, , France

Paris, , France

Toulouse, , France

Paris, , France

Paris, , France

Paris, , France

Bordeaux, , France

Bron, , France

Lille, , France

Marseille, , France

Rennes, , France

Strasbourg, , France

Tours, , France

Patients applied

0 patients applied

Trial Officials

Frank Ruemmele

Principal Investigator

Necker - Enfants Malades Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials